Unilever PLC (ULVR)

Basic

  • Market Cap

    £96.8B

  • EV

    £119.7B

  • Shares Out

    2,502.46M

  • Revenue

    €59.6B

  • Employees

Margins

  • Gross

    100%

  • EBITDA

    19.59%

  • Operating

    16.94%

  • Pre-Tax

    15.67%

  • Net

    10.88%

  • FCF

    13.29%

Returns (5Yr Avg)

  • ROA

    8.66%

  • ROTA

    537.28%

  • ROE

    35.69%

  • ROCE

    20.42%

  • ROIC

    12.13%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    £41.66

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €5,890M

  • Net Debt

    €23.73B

  • Debt/Equity

    1.43

  • EBIT/Interest

    9.73

Growth (CAGR)

  • Rev 3Yr

    5.52%

  • Rev 5Yr

    3.17%

  • Rev 10Yr

    1.81%

  • Dil EPS 3Yr

    6.49%

  • Dil EPS 5Yr

    -5.96%

  • Dil EPS 10Yr

    4.43%

  • Rev Fwd 2Yr

    3.1%

  • EBITDA Fwd 2Yr

    5.33%

  • EPS Fwd 2Yr

    5.97%

  • EPS LT Growth Est

    5.64%

Dividends

  • Yield

  • Payout

    66.35%

  • DPS

    €1.71

  • DPS Growth 3Yr

    1.17%

  • DPS Growth 5Yr

    2.63%

  • DPS Growth 10Yr

    4.75%

  • DPS Growth Fwd 2Yr

    20.1%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Jan '18

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Total Revenues

51,980

50,724

52,444

60,073

59,604

Total Revenues % Chg.

2%

-2.4%

3.4%

14.5%

-0.8%

Cost of Goods Sold, Total

29,102

28,684

30,259

35,906

Gross Profit

22,878

22,040

22,185

24,167

59,604

Selling General & Admin Expenses, Total

12,121

11,882

11,712

13,532

-110

R&D Expenses

840

800

847

908

Other Operating Expenses

-11

2

49,618

Other Operating Expenses, Total

12,961

12,682

12,548

14,442

49,508

Operating Income

9,917

9,358

9,637

9,725

10,096

Interest Expense, Total

-763

-703

-489

-769

-1,038

Interest And Investment Income

224

235

238

305

442

Net Interest Expenses

-539

-468

-251

-464

-596

Income (Loss) On Equity Invest.

176

175

191

208

231

Currency Exchange Gains (Loss)

-58

-25

7

-29

Other Non Operating Income (Expenses)

-9

-20

EBT, Excl. Unusual Items

9,496

9,040

9,575

9,420

9,731

Restructuring Charges

-1,159

-916

-632

-777

-542

Merger & Related Restructuring Charges

-132

-69

-136

-8

-85

Impairment of Goodwill

-18

Gain (Loss) On Sale Of Investments

-22

Gain (Loss) On Sale Of Assets

70

8

-160

2,293

479

Asset Writedown

-17

-263

-55

Legal Settlements

-87

-82

107

Other Unusual Items

32

20

-74

-246

-274

EBT, Incl. Unusual Items

8,289

7,996

8,556

10,337

9,339

Income Tax Expense

2,263

1,923

1,935

2,068

2,199

Earnings From Continuing Operations

6,026

6,073

6,621

8,269

7,140

Minority Interest

-401

-492

-572

-627

-653

Net Income

5,625

5,581

6,049

7,642

6,487

Net Income to Common Incl Extra Items

5,625

5,581

6,049

7,642

6,487

Net Income to Common Excl. Extra Items

5,625

5,581

6,049

7,642

6,487

Total Shares Outstanding

2,613.1

2,622

2,561.8

2,529.3

2,499

Weighted Avg. Shares Outstanding

2,616.5

2,620.3

2,599.9

2,548.2

2,515.9

Weighted Avg. Shares Outstanding Dil

2,626.7

2,629.8

2,609.6

2,559.8

2,532.4

EPS

2.1

2.1

2.3

3

2.6

EPS Diluted

2.1

2.1

2.3

3

2.6

EBITDA

11,881

11,376

10,748

11,015

11,675